Venture Capital

© Lonza

Lonza sets up VC fund for North American health and wellness startups

By Adi Menayang

Swiss pharmaceutical and biotech firm Lonza announced a partnership with US-based Prolog Ventures to create a venture capital fund focusing on products that “maintain, protect, or preserve the health and well-being of people and companion animals.”

Upcoming seminar to focus on financing a CPG company

Upcoming seminar to focus on financing a CPG company

Investment experts and industry-leading entrepreneurs will provide insights and tips on how to improve the odds of successfully obtaining financing during the upcoming “Financing Your Consumer Products Company” seminar.

Fluxome US: “Business as usual” despite euro crisis

Fluxome US: “Business as usual” despite euro crisis

By Shane Starling

The US operation of financially stricken resveratrol supplier, Fluxome, says the cash crisis that has forced closure of its Danish research facility, will not halt resveratrol supply through its US operation.

Virun's technology enables firms to add long chain omega-3 fatty acids EPA and DHA to clear, shelf-stable beverages without affecting odor or taste and without the need for preservatives

Omega-3 delivery expert Virun raises $2.1m to fund expansion plans

By Elaine WATSON

Virun - the firm behind patented technology enabling it to add fat-soluble bioactives from omega-3s to CoQ10 to shelf stable clear beverages - has raised $2.1m from private equity firm Bluestem and private investors to fund its expansion.

L-R: GI Nutrition co-founders Chris and Alex Karsos

60-second interview, Alex Karsos, co-founder, GI Nutrition

How easy is it to break into the sports nutrition market?

There is room in the sports nutrition market for innovative new players, but being a minnow in a pond full of sharks is not easy, Alex Karsos, co-founder of New Jersey-based start-up GI (Grecian Ideal) Nutrition, tells Elaine Watson


Follow us

Featured Events

View more


View more


Featured Suppliers